RETATRUTIDE

Retatrutide 10mg Vial – Triple Agonist Research Peptide (Research Use Only)

Retatrutide (LY3437943) is an advanced triple-hormone receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This unique tri-agonist mechanism produces powerful synergistic effects on glucose control, appetite suppression, energy expenditure, and fat oxidation, making it one of the most promising compounds currently under investigation for obesity, type-2 diabetes, and metabolic syndrome research.

Each sterile vial contains 10mg of lyophilized Retatrutide at ≥99% purity (third-party HPLC & mass-spec verified), delivering exceptional stability and consistency for long-term preclinical and in-vitro studies.

Key research applications:

• Triple-agonist weight loss and body-composition models
• Insulin sensitivity and glycemic control investigations
• Thermogenesis and brown adipose tissue activation
• Appetite regulation via GLP-1/GIP/glucagon pathways
• NAFLD/NASH and cardiovascular risk reduction studies

Product Specifications:

• Strength: 10mg per vial
• Form: White lyophilized powder in sealed glass vial
• Purity: ≥99% (independent lab tested, full COA included)
• Sequence: 39-amino-acid peptide with proprietary modifications
• Molecular Weight: ~4731 g/mol
• Storage: Store at -20°C; stable for 36+ months

Strictly sold for licensed laboratory, scientific, and in-vitro research purposes only. Not for human or veterinary consumption.

Perfect for universities, metabolic research facilities, and pharmaceutical development teams exploring next-generation incretin-based therapies.

Order your Retatrutide 10mg research vial today – third-party tested, cold-chain shipped, discreetly packaged. Limited stock available.